COPD

The AJMC® COPD compendium is a comprehensive resource for clinical news and expert insights for chronic obstructive pulmonary disease.

Latest News

China animation | Image Credit: vegefox.com - stock.adobe.com
COPD Mortality Falls in China, Yet High Burden Persists in Underdeveloped Regions

November 12th 2024

Chronic obstructive pulmonary disease (COPD) burden remains high in underdeveloped regions of China despite a decline in related deaths, highlighting the need for targeted management and prevention strategies.

Bottle of prednisone | Image Credit: luchschenF - stock.adobe.com
Prednisone Superior to Other Corticosteroids for Patients With COPD, Heart Failure

October 30th 2024

Monitoring patient's heart in the ICU | Image Credit: sudok1 - stock.adobe.com
NIVO Score Accurately Predicts Mortality, Noninvasive Ventilation Failure in Patients With AECOPD

October 28th 2024

Lung CT scan | Image Credit: Peakstock - stock.adobe.com
Interstitial Lung Abnormalities in Patients With COPD Linked to Cancer, Heart Failure Risks

October 23rd 2024

COPD illustration | Image Credit: peterschreiber.media - stock.adobe.com
Ineligibility, Limitations to PR Uptake in Patients With AECOPD

October 15th 2024

Type 2 Inflammation: A Common Theme Among Several Chronic Diseases

Learn about the multifaceted aspects of type 2 inflammatory diseases, including impact on quality of life; the role of biomarkers in diagnosis and treatment selection; and unmet needs in clinical management.

Learn about the multifaceted aspects of type 2 inflammatory diseases, including impact on quality of life; the role of biomarkers in diagnosis and treatment selection; and unmet needs in clinical management.
Continuing Medical Education
View All
November 21st 2024

Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies

1.0 Credit / Immunology, Pulmonology/Respiratory

More News

Neon lungs graphic
February 26th 2021

Trial Shows Positive Long-term Safety Profile for Denervation Therapy in COPD

Skylar Jeremias
Results from the AIRFLOW-1 study demonstrate that targeted lung denervation did not produce any severe adverse reactions in patients with chronic obstructive pulmonary disease (COPD) after 3 years.
Sleeping man
February 23rd 2021

Study Finds Triple Therapy for COPD Improves Lung Function During Sleep

Skylar Jeremias
Pulmonary function increased during sleep for patients with chronic obstructive pulmonary (COPD) receiving a triple-therapy regimen, but improvements to quality of life remain to be seen.
Cold weather
February 20th 2021

Hospitalizations, ED Visits for COPD and Asthma Increase Under Certain Weather Conditions

Skylar Jeremias
Changes in temperature and atmospheric pressure were found to be associated with higher rates of medical care utilization for patients with chronic obstructive pulmonary disease (COPD) and asthma.
Rural road
February 17th 2021

Rural Residence Not a Risk Factor for In-Hospital Mortality Among Veterans With COPD

Skylar Jeremias
Living far from a hospital did not increase risk of in-hospital mortality, according to a recent study among veteran populations with chronic obstructive pulmonary disease (COPD).
Lungs
February 13th 2021

Study Finds CV Risk Is Unknown for Many Patients With COPD

Skylar Jeremias
A recent study found that the proportion of patients in the Netherlands with chronic obstructive pulmonary disease (COPD) who are being assessed for cardiovascular (CV) risk does not align with Dutch guideline recommendations.
Neon lungs
February 11th 2021

Pulmonary Embolism Prevalence Appears Lower in Hospitalized Patients With COPD

Skylar Jeremias
The prevalence of pulmonary embolism in certain hospitalized patients with chronic obstructive pulmonary disease (COPD) may be lower than previous research suggests, according to a recent study.
Female physician holding telehealth session
February 5th 2021

Study Identifies COPD Telehealth Services Needing Improvement

Skylar Jeremias
Despite many practices adopting telehealth services to help patients manage their chronic obstructive pulmonary disease (COPD), investigators found that patients and clinicians feel many areas need improvement.
COPD inhaler
February 3rd 2021

Inhaled Sugar Formulation May Reduce Ventilation Duration, Improve Lung Function in AECOPD

Skylar Jeremias
A pilot study among hospitalized patients on the use of an inhaled naturally occurring sugar showed several positive outcomes for those with acute exacerbations of chronic obstructive pulmonary disease (AECOPD).
COPD and Asthma May Not Be Risk Factors for COVID-19, Study Says
January 30th 2021

COPD and Asthma May Not Be Risk Factors for COVID-19, Study Says

Skylar Jeremias
A study found that chronic obstructive pulmonary disease (COPD) and asthma were not risk factors for ICU admission or death as a result of SARS-CoV-2 infection.
grey person with glowing orange lungs
January 27th 2021

ICS Withdrawal Not Found to Increase Risk of COPD-Related Exacerbations

Skylar Jeremias
Physicians can withdraw inhaled corticosteroids (ICS) from triplet therapy without increasing patients’ risk of chronic obstructive pulmonary disease (COPD)-related exacerbations.
Black male patient.
January 23rd 2021

Black Patients Hospitalized With COVID-19 Show High Incidence of Comorbidities, Mortality

Matthew Gavidia
Black patients hospitalized with coronavirus disease 2019 from an urban academic medical center in New York City exhibited high rates of comorbidities and in-hospital mortality, with chronic obstructive pulmonary disease and asthma significantly linked with early death.
Lungs and airway
January 17th 2021

Lymphocyte-HDL Ratio Outperforms Other Biomarkers for Predicting Pulmonary Function in COPD

Skylar Jeremias
Investigators found that the ratio of lymphocytes to high-density lipoprotein (HDL) performed better in predicting pulmonary function than the neutrophil-lymphocyte ratio and the platelet-lymphocyte ratio.
SMIs Linked to Reduced Exacerbations, Readmissions in COPD
January 15th 2021

SMIs Linked to Reduced Exacerbations, Readmissions in COPD

Skylar Jeremias
Investigators using real-world data found that patients receiving treatment from slow mist inhalers (SMIs) had fewer exacerbations and hospitals readmissions compared with patients using dry powder inhalers (DPIs).
Woman in hospital bed
January 14th 2021

Risk of Respiratory Complications, but Not Death, Is Higher for Patients With COPD Who Receive TAVI

Skylar Jeremias
Study findings show that patients with chronic obstructive pulmonary disease (COPD) had increased risks of respiratory complications and pneumonia after undergoing a transcatheter aortic valve insertion (TAVI) compared with those without COPD.
Taking Another Look at Nebulizers for Stable COPD
January 9th 2021

Taking Another Look at Nebulizers for Stable COPD

Skylar Jeremias
A recent review revisited the question of whether inhalers and nebulizers have similar effectiveness to manage stable chronic obstructive pulmonary disease (COPD).
How Lung Macrophages Develop May Have Role in Disease, Study Says
January 2nd 2021

How Lung Macrophages Develop May Have Role in Disease, Study Says

AJMC Staff
Usually, macrophages protect the lungs from attacks. But under certain conditions, lung macrophages can also contribute to severe lung diseases, like chronic obstructive pulmonary disease, or worsen coronavirus disease 2019 (COVID-19).
Study Finds Lack of Health Literacy Does Not Increase Mortality Risk in COPD
December 26th 2020

Study Finds Lack of Health Literacy Does Not Increase Mortality Risk in COPD

Skylar Jeremias
A study from Denmark found that low health literacy was not a risk factor for mortality in patients with chronic obstructive pulmonary disease (COPD) compared with the general population and patients with other chronic conditions.
Top 5 Most-Read COPD Stories of 2020
December 22nd 2020

Top 5 Most-Read COPD Stories of 2020

Skylar Jeremias
The top 5 most-read stories on chronic obstructive pulmonary disease (COPD) of 2020 on AJMC.com focused mainly on ways in which health care treatments for patients can be improved.
FDA Signs Off on EUA for Moderna's COVID-19 Vaccine
December 19th 2020

FDA Signs Off on EUA for Moderna's COVID-19 Vaccine

Allison Inserro
The FDA Friday issued the second Emergency Use Authorization (EUA) for a coronavirus disease 2019 (COVID-19) vaccine, this one to Moderna, as the pandemic reached critical stress points across the country, especially in California.
Patients With COPD Pivot to Telemedicine During Pandemic
December 17th 2020

Patients With COPD Pivot to Telemedicine During Pandemic

Skylar Jeremias
Since the start of the pandemic, many patients with COPD, especially if they experienced an exacerbation during 2020, reported adopting telemedicine, according to a recent study.
Researchers Probe Effect of Diabetes Drugs on COPD Exacerbations
December 12th 2020

Researchers Probe Effect of Diabetes Drugs on COPD Exacerbations

Skylar Jeremias
A recent study found that patients with both chronic obstructive pulmonary disease (COPD) and diabetes using oral hypoglycemic agents had lower risks of severe exacerbations than controls.
FDA Advisory Panel Recommends Pfizer, BioNTech COVID-19 Vaccine
December 10th 2020

FDA Advisory Panel Recommends Pfizer, BioNTech COVID-19 Vaccine

Allison Inserro
The panel was charged with deciding if the benefits of the vaccine outweighs the risks, paving the way for the possibility that immunizations could begin within days.
Multidisciplinary Team-Based Approach Shows Results in WV COPD Primary Care
December 5th 2020

Multidisciplinary Team-Based Approach Shows Results in WV COPD Primary Care

Skylar Jeremias
Clinics that offer a multidisciplinary team-based approach to treat chronic obstructive pulmonary disease (COPD) can provide patients in rural areas access to care and improve their health.
Older man on a stationary bike
December 2nd 2020

Study Finds 3 Key Components That Could Make Pulmonary Rehabilitation More Effective for AECOPD

Skylar Jeremias
A review found that including exercise, breathing techniques, and education components in pulmonary rehabilitation for patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) optimizes such programs.
yellow inhaler placed on top of a pill sheet
November 27th 2020

Study Finds High Rate of Errors in Inhaler Technique and Treatment Nonadherence for COPD

Skylar Jeremias
A study on patients who use inhalers found that interventions to improve inhaler techniques and drug adherence are needed.
lungs
November 24th 2020

HFNC May Improve AECOPD Prognosis Better Than Conventional Therapy

Skylar Jeremias
A recent study found that high-flow nasal cannula may be a better option for first-line oxygen therapy for patients with chronic obstructive pulmonary disease with acute compensated hypercapnic respiratory failure than conventional therapy options.
Lungs with COPD
November 20th 2020

Study Finds Variation in COPD Characteristics by Risk Factors

Skylar Jeremias
Patients with chronic obstructive pulmonary disease (COPD) may experience a difference in symptom severity depending on which risk factors they are exposed to across their lifetime.
x-ray of skeleton showing lungs shaded green for emphasis
November 18th 2020

Who Is More Likely to Receive Referrals for Pulmonary Rehabilitation for COPD?

Skylar Jeremias
While patients with severe chronic obstructive pulmonary disease (COPD) are receiving referrals for pulmonary rehabilitation (PR), female patients and other groups are less likely to receive them.
Cardiac graphic
November 14th 2020

Study Indicates ICS May Reduce New Cardiac Events in Patients With COPD

Allison Inserro
A study looking at chronic obstructive pulmonary disease (COPD) and coronary heart disease found that inhaled corticosteroids (ICS) reduced future cardiac events in patients not known to have coronary heart disease.
Lung art graphic
November 12th 2020

Review Examines Environmental Impact of Inhaler Choice in the UK

Skylar Jeremias
Switching patients from pressurized metered dose inhalers (pMDIs) to dry powder inhalers (DPIs) could both reduce health care system’s carbon footprint and result in more satisfied patients.
<1
...
67891011121314
...
25>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo